Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin/Fenofibrate FDC vs Atorvastatin in T2D with Dyslipidemia
NCT04882293Phase 3Unknown
- Sponsor
- Laboratorios Silanes
- Start
- Feb 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in dyslipidemia, sponsored by Laboratorios Silanes. Status: unknown.
02
Drugs
fenofibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT04882293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882293.